Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NP101 (Sumatriptan Patch) Long-term Safety in Acute Migraine
NCT00792103Phase 3Completed
- Sponsor
- NuPathe Inc.
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Zecuity in migraine, sponsored by NuPathe Inc.. Started Jan 2009; status: completed.
02
Drugs
Zecuity
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00792103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792103.